DI STEFANO, GIUSEPPINA
Dettaglio
DI STEFANO, GIUSEPPINA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Docenti di ruolo di IIa fascia
Pubblicazioni
Risultati 1 - 20 di 43 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. | Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Busi C.; Chieco P.; Kratz F.; Manaresi F.; Pari...ali M. | 2006 | LIVER INTERNATIONAL | 1.01 Articolo in rivista | - | |
2 | A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. | DI STEFANO G.; LANZA M.; KRATZ F.; MERINA L.; FIUME L. | 2004 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
3 | The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells | Manerba M, Di Ianni L, Govoni M, Comparone A, Di Stefano G. | 2018 | PLOS ONE | 1.01 Articolo in rivista | ||
4 | Albumin-drug conjugates in the treatment of hepatic disorders. | Fiume L;Manerba M;Di Stefano G | 2014 | EXPERT OPINION ON DRUG DELIVERY | 1.01 Articolo in rivista | - | |
5 | Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. | Ianni M; Manerba M; Di Stefano G; Porcellini E; Chiappelli M; Carbone I; Licastro F. | 2010 | IMMUNITY & AGEING | 1.01 Articolo in rivista | ||
6 | Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. | Baglioni M.; Fiume L.; Bolondi L.; Farina C.; Kratz F.; Di Stefano G. | 2008 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
7 | Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. | Boga C.; Fiume L.; Baglioni M.; Bertucci C.; Farina C.; Kratz F.; Manerba M.; Naldi M.; Di Stefan...o G. | 2009 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
8 | Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin | Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A. | 2007 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
9 | Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. | FIUME L.; BOLONDI L.; BUSI C.; CHIECO P.; KRATZ F.; LANZA M.; MATTIOLI A.; DI STEFANO G. | 2005 | JOURNAL OF HEPATOLOGY | 1.01 Articolo in rivista | - | |
10 | Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. | Di Stefano G.; Fiume L.; Baglioni M.; Busi C.; Bolondi L.; Farina C.; Mori F.; Chieco P.; Pariali... M.; Kratz F.; Molin L.; Salmaso S.; Caliceti P. | 2008 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
11 | Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. | Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; B...ernardi M. | 2006 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
12 | Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. | Di Stefano G.; Busi C.; Chieco P.; Pariali M.; Fiume L. | 2006 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
13 | Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. | Fiume L.; Baglioni M.; Bolondi L.; Farina C.; Di Stefano G. | 2008 | DRUG DISCOVERY TODAY | 1.01 Articolo in rivista | - | |
14 | Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. | Fiume L.; Manerba M.; Vettraino M.; Di Stefano G. | 2011 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1.01 Articolo in rivista | - | |
15 | Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. | Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Chieco P.; Kratz F.; Pariali M.; Rubini G. | 2008 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
16 | Elevated plasma levels of alpha-1-antichymotripsin in age-related cognitive decline and Alzheimer's disease; a poential therapeutci target. | Porcellini E; Davis EJ; Chiappelli M; Ianni E; Di Stefano G; Forti P; Ravaglia G; Licastro F | 2008 | CURRENT PHARMACEUTICAL DESIGN | 1.01 Articolo in rivista | - | |
17 | Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. | DI STEFANO G.; FIUME L.; BOLONDI L.; LANZA M.; PARIALI M.; CHIECO P. | 2005 | LIVER INTERNATIONAL | 1.01 Articolo in rivista | - | |
18 | Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. | Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Rober...ti M.; Recanatini M. | 2012 | CHEMMEDCHEM | 1.01 Articolo in rivista | - | |
19 | Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. | Fiume L.; Vettraino M.; Carnicelli D.; Arfilli V.; Di Stefano G.; Brigotti M. | 2013 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1.01 Articolo in rivista | - | |
20 | Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 | Vettraino M; Manerba M; Govoni M; Di Stefano G. | 2013 | ANTI-CANCER DRUGS | 1.01 Articolo in rivista | - |